Lung Adenocarcinoma (TCGA, Firehose Legacy)

Summary

Lung Adenocarcinoma (TCGA, Firehose Legacy) is a study catalogued by cBioPortal DataHub under the cancer-type code luad. EvidenceHelix groups it with lung and pleura studies and lists it in the TCGA Firehose Legacy collection.

Study description

TCGA Lung Adenocarcinoma. Source data from GDAC Firehose (http://gdac.broadinstitute.org/runs/stddata__2016_01_28/data/LUAD/20160128/). Previously known as TCGA Provisional.

Text as published in the source's study metadata.

Citation & PubMed

The source lists no citation or PubMed id for this study.

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

luad_tcga

Short name

Lung adeno (TCGA)

Source cancer-type code

luad

Reference genome

not given

Source access groups

PUBLIC

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data. TCGA data are available under the Broad Institute GDAC TCGA Analysis Pipeline License; TCGA-derived records are preliminary or legacy releases.

Citations

The source lists no citation or PubMed id for this study.

Related studies

• Lung Adenocarcinoma (Broad, Cell 2012)

  Whole-exome and/or whole-genome sequencing of 183 lung adenocarcinomas and matched normal tissue pairs.

  Lung and pleuraOther published and consortium studiesSource code luadPubMed 1

• Lung Adenocarcinoma (CAS, Cell 2020)

  Whole-exome sequencing of 103 lung adenocarcinoma cases and their matched normals in Chinese patients.

  Lung and pleuraOther published and consortium studiesSource code luadPubMed 1

• Lung Adenocarcinoma (CPTAC, Cell 2020)

  Whole genome (WGS) or whole exome sequencing (WES) of 110 tumors and 101 matched normal adjacent tissues in lung adenocarcinoma. Proteogenomic characterization generated by CPTAC.

  Lung and pleuraOther published and consortium studiesSource code luadPubMed 1

• Lung Adenocarcinoma (MSK, 2021)

  Targeted sequencing of 186 matched normal samples from 186 lung adenocarcinoma patient via MSK-IMPACT.

  Lung and pleuraMSK studiesSource code luad

• Lung Adenocarcinoma (MSK, J Thorac Oncol 2020)

  Targeted sequencing of 604 lung adenocarcinoma tumor/normal pairs via MSK-IMPACT.

  Lung and pleuraMSK studiesSource code luadPubMed 1

• Lung Adenocarcinoma (MSK, NPJ Precision Oncology 2021)

  Targeted sequencing of 426 matched normal samples from 426 lung adenocarcinoma patients.

  Lung and pleuraMSK studiesSource code luadPubMed 1

• Lung Adenocarcinoma (MSK, Science 2015)

  Whole-exome sequencing of 34 non small cell lung cancer tumor/normal pairs.

  Lung and pleuraMSK studiesSource code luadPubMed 1

• Lung Adenocarcinoma (OncoSG, Nat Genet 2020)

  Whole-exome and transcriptome sequencing of 305 east asian lung adenocarcinomas with matched normals. Courtesy of OncoSG (https://src.gisapps.org/OncoSG/). Lung Cancer Consortium Singapore (LCCS).

  Lung and pleuraOther published and consortium studiesSource code luadPubMed 1

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.